so Michele, who is living with PNH, can spend more time riding her beloved horse

Male Apellis employee holding a horse saddle

Supply Chain at Apellis

We are a global biopharmaceutical company leveraging courageous science, creativity, and compassion to deliver life-changing medicines. By pioneering targeted C3 therapies, we aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.

Learn More
Folded page of a newspaper

Latest news

June 12, 2020

New Pivotal Data Demonstrate Superiority of Apellis’ Pegcetacoplan to Eculizumab in Improving Hemoglobin Levels, Independent of Prior Transfusions, in PNH

June 10, 2020

Apellis Announces Investor Conference Call to Discuss Phase 3 PEGASUS Data to be Presented at the 25th Annual Congress of the European Hematology Association (EHA)

June 4, 2020

Apellis Pharmaceuticals to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

A man with a baby in a baby carrier

At the heart of our company is the belief that exceptional science and compassion are not mutually exclusive.

Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

We are advancing therapies

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

Our lead investigational products

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.


we replace impossible with How

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
Female Apellis employee holding a pug

Quality Assurance at Apellis